scispace - formally typeset
H

Hiroshi Maeda

Researcher at Kumamoto University

Publications -  915
Citations -  67944

Hiroshi Maeda is an academic researcher from Kumamoto University. The author has contributed to research in topics: Neocarzinostatin & Nitric oxide. The author has an hindex of 103, co-authored 893 publications receiving 63370 citations. Previous affiliations of Hiroshi Maeda include Osaka University & Okayama University.

Papers
More filters
Journal ArticleDOI

Activation of hageman factor and prekallikrein and generation of kinin by various microbial proteinases.

TL;DR: The enhancement of vascular permeability in guinea pig skin and its sensitivity to inhibitors of activated Hageman factor, plasma kallikrein, or a kininase were examined and the results from the in vivo experiments were consistent with those in vitro.
Journal ArticleDOI

Partial Melt Growth Process of Bi2Sr2Ca1Cu2Ox Textured Tapes on Silver

TL;DR: Bi2Sr2Ca1Cu2Ox textured tapes with an excellent Jc were synthesized by doctor-blade casting and a melt process as mentioned in this paper, where green tape was laid on a silver foil and oxide/silver composite tape was heat treated.
Journal ArticleDOI

SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours

TL;DR: Data indicate that i.v. administration of SMA-Dox micellar formulation can enhance the therapeutic effect of doxorubicin while reducing greatly cardiac and bone marrow toxicity, which should allow safe use of high doses of this agent.
Journal ArticleDOI

Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth

TL;DR: The role of NO in solid tumor pathology was further investigated in animal tumor and a possible connection between nitric oxide (NO) and enhanced vascular permeability in solid tumors was reported.
Journal ArticleDOI

Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application

TL;DR: The EPR effect was enhanced by applying nitroglycerin (NG) ointment on the skin of tumor‐bearing animals, and thus enhanced the delivery of the drug to tumors, and enhanced therapeutic effects.